Researchers found differences in how respiratory syncytial virus spreads among children in rural versus urban communities and ...

A winter virus that can mimic the symptoms of a common cold is causing concern as it can be particularly serious for some ...

The preventive effects of nirsevimab against respiratory syncytial virus infection persisted for up to 12 months after ...

Background Respiratory syncytial virus (RSV) is an important cause of acute lower respiratory infections (ALRI) among under-5 ...

Cases of RSV and flu are ticking up among young children in the U.S. even as overall respiratory virus activity remains low, ...

NEW YORK CITY -- In September, an 8-month-old baby came into Dr. Juanita Mora's office in Chicago with an infection the doctor hadn't expected to see for another two months: RSV. Like her peers across ...

Nirsevimab is a long-acting monoclonal antibody that provides season-long protection against RSV in infants, reducing ...

Respiratory syncytial virus (RSV) is a common respiratory virus which usually causes mild, cold-like symptoms during the ...

VBY329 is designed for the prevention of Respiratory Syncytial Virus (RSV) infections in newborns, infants, and children, and results from ...

Much is known about the role that respiratory syncytial virus (RSV) plays in infant hospitalization, but much less is known about the total burden of RSV illness as manifested by myriad outpatient ...